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Abstract. MAP 4 is a ubiquitous microtubule-associ- 
ated protein thought to play a role in the polymeriza- 
tion and stability of microtubules in interphase and mi- 
totic cells. We have analyzed the behavior of protein 
domains of MAP 4 in vivo using chimeras constructed 
from these polypeptides and the green fluorescent pro- 
tein (GFP). GFP-MAP 4 localizes to microtubules; this 
is confirmed by colocalization of GFP-MAP 4 with mi- 
crotubules that have incorporated microinjected 
rhodamine-tubulin, and by loss of localized fluores- 
cence after treatment of cells with anti-microtubule 
agents. Different subdomains of MAP 4 have distinct 
effects on microtubule organization and dynamics. The 
entire basic domain of MAP 4 reorganizes microtu- 
bules into bundles and stabilizes these arrays against 
depolymerization with nocodazole. Within the basic 
domain, the PGGG repeats, which are conserved with 
MAP 2 and tau, have a weak affinity  for microtubules 
and are dispensable for microtubule binding, whereas 
the MAP 4-unique PSP region can function indepen- 
dently in binding. The projection domain shows no mi- 
crotubule localization, but does modulate the associa- 
tion of various binding subdomains with microtubules. 
The acidic carboxy terminus of MAP 4 strongly affects 
the microtubule binding characteristics of the other do- 
mains, despite constituting less than 6% of the protein. 
These data show that MAP 4 association with microtu- 
bules is modulated by sequences both within and out- 
side the basic domain. Further, our work demonstrates 
that GFP chimeras will allow an in vivo analysis of the 
effects of MAPs and their variants on microtubule dy- 
namics in real time. 
p 
ROPER assembly and organization of the microtubule 
cytoskeleton  are  required  for  cellular  processes 
such as mitosis, organelle transport, and the estab- 
lishment of cell shape and polarity. For microtubules to 
function in such varied processes,  they must be amenable 
to change and their lability must be controlled. The lability 
of microtubules derives from their dynamic instability, i.e., 
rapid changes between phases of depolymerization and re- 
growth (18, 26, 51). The control of dynamic instability and 
the selective stabilization  of particular populations of mi- 
crotubules are essential for the preservation of normal mi- 
crotubule organization within cells (reviewed in reference 
32). In some cases, stable and transient microtubules are 
characterized by post-translational modifications of tubu- 
lin  (13, 23). Structural  microtubule-associated proteins 
(MAP)  1  may also play essential roles in determining the in 
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vivo characteristics  of individual microtubules and dictat- 
ing the state of microtubule assembly in a cell (20, 43, 54). 
MAPs are identified by their copurification with tubulin 
and  association  with microtubules both  in vitro  and in 
vivo. They are divided into two broad categories:  motor 
MAPs (the kinesin [5] and dynein [33] superfamilies)  and 
structural MAPs (MAPIA, MAPIB, MAP 2, MAP 4, tau 
(reviewed  in  references  32,  43,  54), ensconsin  (12), 
EMAP115  (49), X-MAP (2, 25). Structural MAPs are ge- 
nerically  associated  with increased microtubule assembly 
and stability, as demonstrated in a number of in vitro anal- 
yses. Studies in which the major neural MAPs, MAP 2 and 
tau, were either overexpressed in vivo in heterologous sys- 
tems (37, 38, 40, 44, 62) or eliminated using antisense tech- 
nology (16, 17) have further implicated these proteins in 
both  microtubule  stabilization  and  organization  during 
neurogenesis.  Recent results from knockout of the mouse 
tau  gene  indicate,  however,  that  neural  MAPs  may be 
functionally redundant (31). MAP 4 is more ubiquitous 
than the neuronal MAPs, and its functions in cytoskeletal 
organization in vivo are unknown. 
MAP 4 is a group of related thermostable polypeptides 
that migrate on polyacrylamide gels with an apparent Mr 
of 200-240 kD (8, 11, 53, 55). Its expression is nearly ubiq- 
uitous (10, 57) and it is localized  to both interphase and 
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coded by a single gene from which multiple messages are 
transcribed  (21,  63),  and  some  of  the  protein  isotype 
diversity  arises  from  alternative  splicing  (reference  20 
and unpublished  data).  Differences may also arise from 
cell cycle-dependent changes in MAP 4 phosphorylation 
(59, 60). 
The presence and conservation of distinct protein do- 
mains within MAP 4 have been inferred from comparisons 
of sequences from human, mouse and bovine sources (63). 
MAP 4 has two major charge domains, an acidic domain 
that projects from the microtubule surface and a basic re- 
gion that contains sequences responsible for microtubule 
binding (Fig. 1 A). The acidically charged NH2-terminal 
projection domain consists principally of a region contain- 
ing a  variable number  of 14-amino  acid  degenerate re- 
peats (the KDM repeats); these are proposed to form mul- 
tiple short a-helices. The extreme amino terminus of the 
protein  (N)  is  a  highly  conserved domain  of unknown 
function. The basic domain constitutes about one third of 
the protein. It comprises a region unique to MAP 4 and a 
region  containing  several  18-mer  degenerate  repeats 
(PGGG) that are similar to sequences found in MAP 2 
and tau  (46). Alternative splicing generates variations in 
the number and type of repeats, but this region has been 
considered the canonical microtubule binding domain in 
these MAPs (see in vitro binding studies in references 15, 
22, 36). The portion of the basic domain unique to MAP 4 
can be divided into two domains: a highly conserved re- 
gion that is rich in proline (P) and a region abundant in 
serine and proline (SP). The latter region contains con- 
served sites of potential phosphorylation, including a con- 
sensus site for cdc2 kinase. MAP 4 also has a short acidic 
carboxy terminus (C) that is highly conserved across spe- 
cies, but it shares only minimal similarity with the corre- 
sponding terminal regions in other MAPs. 
This paper describes the use of chimeras of MAP 4 and 
a recently discovered reporter molecule, green fluorescent 
protein (GFP), to examine the behavior of MAP 4 and its 
subdomains in living cells. GFP is a 238 amino acid protein 
from the jellyfish Aequorea victoria; it absorbs light at 395 
and 470 nm, emits light prominently at 510 nm, and can be 
detected using standard epifluorescence filters for fluores- 
cein (34, 58). The utility of GFP as a marker in living cells 
has been demonstrated in elegant studies on cellular mi- 
gration in Caenorhabditis elegans (19) and particle move- 
ments during Drosophila oogenesis (61). Our in vivo anal- 
yses  of  GFP-MAP  4  chimeras  demonstrate  that  this 
reporter molecule can also be used to track the subceUular 
reorganization of cytoskeletal elements. The lack of toxic- 
ity of these chimeras and the ability to select stable cell 
lines expressing GFP-MAP 4 has enabled Us to determine 
the contributions made by individual MAP 4 domains to 
microtubule binding and organization in vivo. 
Materials and Methods 
Cell Culture 
All cell lines were grown at 37°C with 5% CO2 +  95% air in F-12 nutrient 
media supplemented with 10%  fetal bovine serum. Cultures were split 
and passaged using standard trypsinization procedures. 
Construction of Vectors  for Expression of Tagged MAP 
4 Domains 
The constructs discussed in this paper are summarized in Fig. I B. GFP ex- 
pression vectors were made in either pRc/CMV or pCR3 (Invitrogen, San 
Diego, CA) through PCR and subcloning. To generate vectors that would 
express GFP  in mammalian cells, we initially made constructs that en- 
coded GFP alone. The GFP coding region was amplified from the pGFP 
10.1 plasmid (reference 19; generous gift of Dr. Martin Chalfie, Columbia 
University, NY) using a 5' primer containing a HindlII restriction endo- 
nuclease site and the first 26 nt of GFP coding sequence, and a 3' primer 
containing the last 20  nt  of GFP  coding sequence, excluding the stop 
codon, and either a NotI or HindIII restriction endonuclease site. In initial 
experiments, the  amplimer was  ligated  directly  to  the  epitope-tagged 
MAP 4 constructs described below using the HindIII sites. In subsequent 
experiments, the HindIII/NotI amplimers were used for ligation into pRc/ 
CMV alone, or into MAP 4 constructs that had been generated by sub- 
cloning and/or PCR with NotI/ApaI sites. In these latter cases, the open 
reading frame between the 3' end of the GFP coding region and the MAP 
4 inserts was maintained by the addition of a single nucleotide at the 3' 
side  of the Nod  site. The complete  GFP  sequence was  confirmed by 
sequencing of the amplimer; it contained the substitution at position 264 
reported previously (19).  Constructs were restriction mapped and then 
sequenced at  their  ends to  confirm  the  integrity  of  the  GFP-MAP  4 
chimeras. 
Additional expression constructs were made through PCR amplifica- 
tion from existing GFP constructs using a 5' GFP primer and MAP 4-spe- 
cific 3' primers, each with engineered translation termination codons and 
a 3' ApaI restriction endonuclease site. For the PGGG and PGGGC con- 
structs, MAP 4 sequences were PCR amplified with a 5' NotI site and sub- 
cloned into pCR3 already containing GFP with the 3' Nod restriction site. 
PCR products encoding GFP fused to all remaining MAP 4  sequences 
were  subcloned according to  manufacturer's protocol  directly  into  the 
pCR3 vector included in the eukaryotic TA cloning kit (Invitrogen, San 
Diego, CA). All fusions were restriction mapped and sequenced at their 
ends to determine insert orientation and fidelity. 
For some experiments, MAP 4 domains were generated with an epi- 
tope tag by making constructs incorporating the nine amino acid hemag- 
glutinin (HA) sequence (YPYDVPDYA) from influenza virus (41); this is 
recognized by the 12CA5 mAb (Babco, Richmond, CA). The epitope was 
placed at the 5' efid of the basic domain (BD) of MAP 4, or 5' to the PSP 
and PGGG regions of the MAP 4 BD separately, using PCR amplification 
with appropriate primers. Each 5' primer contained a HindIII restriction 
endonuclease site, a translation initiator codon, the 27-nt sequence for the 
epitope, and sequence specific for the MAP 4 region of interest. The 3' 
PCR primers for each construct encoded both a translation termination 
codon and an XbaI restriction endonuclease site. PCR products were pu- 
tiffed, restriction digested, and used for subcloning into similarly digested 
pRc/CMV plasmid. After subcloning, all constructs were  sequenced at 
both ends to ensure proper amplification of MAP 4 domains. 
rransfection 
All cell lines were transfected using Lipofectamine (GIBCO BRL, Gaith- 
ersburg, MD), with some minor modifications of the manufacturer's pro- 
tocol. For Cos-7 cells, 1 i~g of DNA was used with 8 Id of liposomes, while 
all other ceils were transfected with 1 Ixg of DNA and 6 ~1 of liposomes. 
Purified DNA was prepared using columns (Qiagen, Chatsworth, CA), 
and for most transfections, serum-free DME was used in place of OPTI- 
MEM (GIBCO BRL) medium. Ceils were incubated at 37°C and 5% CO2 
in the presence of DNA-liposome complexes for 2.5 h (5 h for Cos-7 ceils), 
after  which the  solution was  replaced  with  standard growth  medium. 
Transfectants were then analyzed at various times for expression of exog- 
enous protein. In some cases, ceils were first allowed to recover for 5 h 
and were then treated with 2  mM sodium butyrate to enhance general 
transcription levels. 
Selection of Stable Cell Lines 
Both BHK and CHO cell lines were used for the isolation of ceils stably 
expressing MAP 4 constructs. Ceils with stably integrated plasmids were 
selected by growing transiently transfected cells in the presence of 2 mg/ 
ml G418, a neomycin analogue (GIBCO BRL). Clonal isolates were ob- 
tained through serial dilution of stable transfectants into 96-well plates, af- 
ter which they were amplified and seeded onto glass coverslips in 35-mm 
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containing 2 mg/ml G418. 
Microinjection 
Cells (PtK, 3T3, BHK, or Cos-7) grown on coverslips were microinjected 
as described previously (56)  in  a  chamber that contained F-12  supple- 
mented with 10%  fetal bovine serum and 13  mM Hepes, pH 7.0.  Con- 
struct DNA was injected at 1 mg/ml in PBS, pH 7.0, and in some experi- 
ments, 1 mg/ml Lucifer Yellow (Molecular Probes, Inc., Eugene, OR) was 
added to identify injected cells. Rhodaminated tubulin (28) with 3.9 mol 
rhodamine/tubulin dimer (obtained from Molecular Probes) was microin- 
jected at a concentration of 1 mg/ml. These injections were performed in 
the absence of tracer dye on cells that were transiently transfected with 
the GFP-MAP 4 construct. 
Observation of Live Cells 
Living cells grown on coverslips were mounted on depression slides in 200 
i~1 of growth medium. Preparations were sealed with Valap (1:1:1 mixture 
of Vaseline, lanolin, and paraffin wax) and viewed for extended time peri- 
ods in an air curtain to maintain the cells at 37°C. For perfusion experi- 
ments, solutions containing anti-microtubule agents or methanol were ap- 
plied to one side of a coverslip elevated on a standard microscope slide 
with two strips of parafilm. A  channel was made in the Valap and the ap- 
plied solution was drawn through the channel by capillary action using fil- 
ter paper. 
Anti-Microtubule Drug Treatments 
Cells grown on glass coverslips were incubated in the presence of 10 ~g/ml 
nocodazole (diluted from a  1 mg/ml solution made in DMSO) for up to 
2.5 h. For taxol treatment, a 10 mM solution in DMSO was diluted to a fi- 
nal concentration of 10 ixM and applied to cells for 4-6 h. After drug treat- 
ment, cells expressing GFP-chimeras were either observed directly, or af- 
ter fixation for 7 min in 100% dry methanol at -20°C. 
Chemical and Immunostaining 
Cells were fixed in methanol as described above for all antibody staining. 
After fixation, cells were washed three times in an equal volume of PBS at 
pH 6.8. Incubation with primary and secondary antibodies was performed 
in a  humid chamber at 37°C for 1 h. All antibody incubations were fol- 
lowed by 20-min washes in PBS +  0.01% Tween 20. mAb against a-tubu- 
lin (Amersham Corp., Arlington Heights, IL) was used at 1:500 dilution 
and the 12CA5 monoclonal (Babco) was used at a 1:250 dilution. All sec- 
ondary antibodies (Jackson Immunoresearch Laboratories, West Grove, 
PA) were used at 1:100 dilutions. 
Microscopy~Image Analysis 
Most  images  were  obtained  using  conventional  Nikon  (Nikon  Inc., 
Melville, NY)  or Zeiss microscopes equipped with standard fluorescein 
filter  sets and using a  Zeiss 100×  planachromat lens (Carl  Zeiss, Inc., 
Thornwood,  NY).  GFP  images were  either  photographed  directly  on 
Kodak T-Max 400 film (exposures of 2 s to 1 min) or captured using a SIT 
camera and transferred to  Image-1 software (Universal Imaging, West 
Chester, PA). Hard copies of stored images were obtained by formatting 
slides from Adobe Photoshop TIFF files and printing color photographs 
either from internegatives or directly using a Fuji 200II Pictrostat printer 
(Fuji Medical Systems, Stamford, CT). Comparative analyses of noncali- 
brated fluorescence intensity were carried out using Image-1 software. In 
brief, images of individual cells from the same coverslip were taken using 
a SIT camera with values for voltage, gain and black level preset at appro- 
priate values to accommodate a range of fluorescence intensities without 
saturating the camera. Images of cells were taken after photoactivation of 
GFP had occurred. For each cell, both the total area and the total pixel 
density were measured and used to calculate the pixel intensity per area. 
Confocal images were obtained using a Bio-Rad MRC-1000 Confocal 
System (Bio-Rad Labs, Richmond, CA) and a Nikon Diaphot microscope 
equipped with a  Nikon 60×  water immersion objective. Excitation was 
with the 488 line of a krypton-argon laser operating at 1% power. Images 
presented in the paper were generated from two consecutive 0.8-s scans of 
a single Z  axis. Images were obtained at SUNY Buffalo with the invalu- 
able assistance of Dr. R. Summers (SUNY Buffalo) and Mr. C. Blanchard 
(Bio-Rad Labs., Richmond, CA). 
Results 
Expression  Constructs and General Observations 
To examine the behavior of MAP 4  and its subdomains, 
mammalian expression vectors were constructed encoding 
the sequences of interest. The region of MAP 4 expressed 
and the type of reporter used for each construct are illus- 
trated in Fig.  1. All sequences were inserted downstream 
from the cytomegalovirus promoter for high level expres- 
sion in mammalian cells. Constructs were introduced into 
multiple cell types via liposome-mediated transfection or, 
less frequently, by microinjection. Results were similar for 
any given construct regardless of either the method of in- 
troduction of plasmid or the cell type used. Although the 
majority of images shown here were obtained with GFP- 
chimeras, similar results were seen for the same domains 
using HA-tagged constructs.  In most cases, transcription 
was generically increased by addition of sodium butyrate 
to the  tissue  culture  medium.  However, the  presence or 
absence of sodium butyrate had no effect on the general 
phenotypes observed. 
Figure 1.  Schematic  representa- 
tion  of  chimeric  proteins  pro- 
duced by  eukaryotic  expression 
vectors.  (A)  Representation  of 
MAP  4  protein showing the ba- 
sic domains attached to the sur- 
face of the microtubule, and the 
acidic  domains  projecting  from 
the  surface.  (B)  The  portion  of 
MAP  4  made  and  the  reporter 
tag (GFP or HA) present at the 
amino terminus are shown. Des- 
ignation  of  regions  is  based  on 
the analysis presented in West et 
al. (63). 
Olson et al. Behavior of GFP-MAP 4 Constructs In Vivo  641 Figure 2.  Live BHK cell transfected with GFP. Cells were tran- 
siently transfected with the GFP construct and then treated for 24 h 
with 2 mM sodium butyrate. Note the distribution of fluorescence 
in both cytoplasm and nucleus, although the nucleoli largely ex- 
clude the construct. 
GFP-MAP 4 Is Specifically Localized to 
Microtubules  while GFP Alone Distributes Evenly 
throughout  the Cell 
We  asked  whether  GFP could be  used  as  a  reporter of 
MAP behavior in living cells by making a GFP fusion with 
full-length mouse MAP 4 and comparing its localization to 
that  of a  construct  encoding  GFP  alone.  The  plasmids 
were introduced into a  variety of cell types by transient 
transfection. Stable cell lines of CHO and BHK expressing 
GFP-MAP 4 were also isolated using the neomycin resis- 
tance marker on the pRc/CMV plasmid. 
Cells transfected with a construct encoding GFP alone 
displayed diffuse fluorescence throughout the  cytoplasm 
and nucleus (Fig. 2). These data indicate that GFP is ex- 
pressed well in mammalian cells,  as had been previously 
demonstrated both in invertebrates and bacteria (19, 61). 
The presence of GFP in both the  nucleus and  the cyto- 
plasm also suggested that specific distributions of chimeric 
molecules  in  either  of  these  compartments  would  be 
readily detectable. After 24 h, clonal populations of green 
cells could be identified, indicating that expression of GFP 
had no adverse effect on cell division. 
Illumination of transfected cells often caused the fluo- 
rescence  to  intensify  ~5-10  fold  within  a  few  seconds. 
High-level fluorescence was then maintained  for several 
minutes before significant bleaching was seen. This obser- 
vation, which pertained to GFP and all of the GFP-MAP 4 
chimeras, suggests that this reporter may be useful in pho- 
toactivation assays. 
Cells  transfected  with  a  fusion  of GFP  to  full-length 
MAP 4 showed fluorescent arrays typical of the interphase 
microtubules in these cells (Fig. 3). The patterns were sim- 
ilar in cells that contained little  (CHO; Fig. 3 D) or sub- 
stantial (BHK; Fig. 3, A-C) amounts of endogenous MAP 
4;  they were  also  similar  in  stable  or transient  transfec- 
tants. In contrast to observations with GFP alone, no dif- 
fuse labeling  of the  cytoplasm or nucleus was observed. 
Arrays typically originated from a focus reminiscent of a 
centrosome  (Fig.  3,  B  and  C).  Thus,  the  patterns  were 
characteristic of normal microtubule arrays and resembled 
those  seen  previously in  immunofluorescent analyses  of 
CHO cells  stably expressing human MAP 4 (3).  Labeling 
of spindles indicated that the GFP-MAP 4 was also local- 
ized to mitotic microtubules (data not shown), as expected 
based on the distribution of endogenous MAP 4. The ab- 
sence  of  microtubule  abnormalities  in  the  presence  of 
GFP-MAP 4  expression  is  consistent  with  our  previous 
analyses using untagged human MAP 4 expressed in CHO 
cells (3), and further indicates that GFP protein does not 
interfere with normal cellular functions detectable in these 
assays. In the stable transfectants, however, we noted that 
fluorescence intensity varied significantly between individ- 
ual ceils, even those of clonal origin. These results may re- 
flect a physiologically significant property of chimera ex- 
pression (variation during cell cycle, etc.), or could be due 
to variations in the rate at which newly synthesized GFP 
folds to generate a fluorescent molecule. 
To confirm that the GFP-MAP 4 chimera was on micro- 
tubules,  cells  that  were  stably  or  transiently  transfected 
with GFP-MAP 4 were injected with rhodaminated tubu- 
lin. As shown in Fig. 4, the signals are coincident, with mi- 
crotubules  labeling  evenly  along  their  length  with  the 
MAP 4 fusion protein. 
The  utility  of  GFP-chimeras  for  following  dynamic 
events of the cytoskeleton in vivo is illustrated  in Fig. 5. 
Confocal images of an optical section of a  BHK cell ex- 
pressing GFP-MAP 4 were taken 30 s apart; changes in in- 
dividual microtubules can be readily visualized. Over the 
several minutes this or other cells were imaged using con- 
focal laser scanning, there was no loss of fluorescence in- 
tensity or apparent effect on cell viability. These data are 
similar to those we obtained on GFP constructs using con- 
ventional  fluorescence  microscopy. Unlike  proteins  that 
have been covalently modified with fluorescein-based flu- 
orophores (56), the level of GFP fluorescence does not di- 
minish significantly during image acquisition; for our ex- 
Figure 3.  Images of live cells stably or transiently  transfected 
with the GFP-MAP 4 construct. BHK (A-C) or CHO (D) cells 
were either transiently (A and B) or stably (C and D) transfected 
with GFP-mouse MAP 4. Fluorescence is localized to microtu- 
bule arrays, and no diffuse cytoplasmic signal is present. Aster- 
isks indicate positions of microtubule organizing centers. 
The Journal of Cell Biology,  Volume 130, 1995  642 Figure 4.  Colocalization of MAP 4 and tubulin in a live BHK cell. BHK cells were transiently transfected with the GFP-MAP 4 con- 
struct and incubated at 37°C for 24 h to allow expression of the vector. Cells were then microinjected with a solution containing 1 mg/ml 
rhodaminated  tubulin and allowed to recover overnight before observation. Visualization of both rhodamine-tubulin  (A) and GFP- 
MAP 4 (B) shows that the patterns are coincident. 
periments with conventional microscopes, the use of low 
light-level  imaging was  optional.  Further,  cells  that  had 
been continuously illuminated for photography for peri- 
ods as long as i min were observed to undergo cell division 
during the next 24-h period, suggesting negligible photo- 
toxicity under the conditions of these observations. 
These initial experiments demonstrated the utility of the 
GFP constructs for studying the subcellular  dynamics of 
MAP 4 and associated structures in vivo, and led to further 
investigations of MAP 4  subdomains using this  technol- 
ogy. Our analyses are detailed further in the following sec- 
tions, but two points are of particular note. First, the cellu- 
lar distribution of GFP chimeras was similar to what we 
Figure 5.  Dynamics of GFP-MAP 4 expressed in a stably trans- 
fected BHK cell. Images were recorded  using confocal micros- 
copy as outlined in Materials and Methods. B shows the same op- 
tical section as in A, but was recorded 30 s later. Arrows point to 
some of the regions in which changes in GFP-MAP 4 organiza- 
tion are evident. 
observed previously using epitope-tagging methods; an ex- 
ample of one of the HA-tagged constructs is shown subse- 
quently (see Fig. 7). However, because the cells were not 
processed for immunostaining, it was possible to assess the 
distribution of protein in localized and nonlocalized states 
without  the  uncertainties  that  accompany fixation.  Sec- 
ond,  correlations  could  be  made  between  degrees  of 
MAP-induced perturbation  and  the  expression  level  for 
each construct, since the intensity of fluorescence served 
as an indicator of the concentration of the chimera. 
The MAP 4 Basic Domain Causes Microtubule 
Rearrangements 
We initiated examination of MAP 4 domains by generat- 
ing GFP chimeras containing the entire basic domain. Fig. 
6 illustrates  that this construct (GFP-BD) causes unique, 
cell-type independent rearrangements of the microtubule 
cytoskeleton. There is  a  range of phenotypic abnormali- 
ties,  including  microtubule  bundles  (Fig.  6,  C  and  D), 
whorls of microtubules around the nucleus (Fig. 6 C) and 
more rarely,  polygonal arrays with  noncentrosomal foci 
(Fig. 6 B). A few cells in each preparation appeared more 
or less normal (Fig. 6 A). The diverse effects elicited by 
GFP-BD expression suggested that the extent of microtu- 
bule reorganization might reflect differences in expression 
levels of the chimera. To test this interpretation, we corre- 
lated the amount of GFP-fluorescence with the extent of 
microtubule  rearrangement.  Using  a  semiquantitative 
measure of relative fluorescence, we determined that cells 
displaying the most severe bundling of microtubules had 
fluorescence  intensities  2.5-3-fold  higher  than  less  per- 
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versus polygonal arrays are not known. As with the full- 
length  MAP 4,  however, diffuse fluorescence was never 
seen  with  the  GFP-BD  construct,  indicating  that  both 
these chimeric proteins have a  high affinity for microtu- 
bules. 
The rearrangements seen with GFP-BD were identical 
to those observed by immunofluorescence in a variety of 
cell types transfected with the basic domain tagged at its 
amino  terminus  with  the  nine-amino  acid  HA  epitope 
(Fig. 7).  These data suggest that the  rearrangements are 
specific to the basic domain of MAP 4  and are indepen- 
dent  of the  reporter  used  to  detect  them.  Comparisons 
made  for a  number of constructs  (see  Table  I  for sum- 
mary) yielded similar conclusions on the innocuous nature 
of the larger GFP reporter versus the small epitope tag on 
the in vivo behaviors of the chimeras. 
Figure 6.  Living  cells  transiently  and  stably  transfected  with 
GFP-BD construct. (A) Stably transfected BHK cell expressing a 
low level of chimeric protein; no butyrate treatment. (B) Tran- 
siently transfected BHK cell expressing  high levels of chimeric 
protein; treated for 2 mM sodium  butyrate for 36 h. The arrow 
points  to an area rearranged into a lattice  from an apparently 
noncentrosomal region.  (C) Transiently transfected Cos-7 cell, 
treated as in B. (D) Transiently  transfected BHK cell expressing 
high levels of chimeric  protein;  treated with 2 mM sodium  bu- 
tyrate for 24 h. Note the extensive  rearrangement of microtu- 
bules in the cells expressing higher amounts of chimeric protein. 
turbed cells. Cells with very low overall fluorescence, such 
as shown in Fig. 6 A, contained more normal microtubule 
arrays. These data suggest that the severity of the pheno- 
type  is  related  to  the  level  of transgene  expression,  al- 
Separation  of the Basic Domain into PSP and PC~47 
Components Indicates Distinct Microtubule Binding 
Contributions for Each Region 
To  examine  the  individual  regions  within  the  basic  do- 
main, we generated constructs containing either the MAP 
4 unique flanking sequence (GFP-PSP) or the PGGG re- 
peat  domain  conserved  with  MAP  2  and  tau  (GFP- 
PGGG). The GFP-PSP chimeric protein caused microtu- 
bule  rearrangements reminiscent  of those  observed with 
the entire basic domain, but displayed a lower affinity for 
microtubules,  as indicated  by the  distribution  of fluores- 
cence in both localized and diffuse states (Fig. 8 A). The 
majority of fluorescence was localized to the most severely 
rearranged microtubules. These results are similar to our 
observations using the  same MAP fragment tagged with 
the HA epitope, although diffuse fluorescence was not ob- 
served in this latter case because of extraction of the un- 
bound  molecules  during  processing  for  immunostaining 
(data not shown; see also Table I). As with the intact bind- 
ing  domain,  the  PSP  region  displayed  increased  pheno- 
typic severity at higher expression levels. Since the overall 
fluorescence  levels  of  cells  expressing  GFP-PSP  were 
equivalent  to  those  containing  GFP-BD  constructs,  we 
conclude  that  the  less  severe  phenotype  observed  re- 
flected a decreased affinity of GFP-PSP for microtubules. 
Cells  transfected  with  GFP-PGGG  showed  a  largely 
nonlocalized  fluorescence, regardless  of expression level 
(Fig. 8 B). Decoration of microtubules was extremely rare, 
and the cells resembled those transfected with GFP alone. 
These observations are consistent with in vivo results for 
the PGGG repeats of MAP 2  and tau  (37, 44), but  they 
contrast with in vitro results that show an affinity of these 
domains for microtubules (6, 15, 22, 27, 29). Our observa- 
tions with the GFP-PSP and GFP-PGGG chimeras in vivo 
suggest  that  the  high  affinity microtubule  binding  seen 
with the entire basic domain results from enhanced bind- 
ing generated by a combination of the PSP and PGGG re- 
gions. 
The Acidic Carboxy Terminus of  MAP 4 Affects the 
Interaction of the Protein with Microtubules 
Because the  acidic COOH-terminal domain of MAP 4 is 
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Expression Vectors 
MT  MT  Diffuse 
Construct  binding  bundling  labeling 
GFP  -  -  ++++ 
GFP-MAP4  +  +  +  +  -  - 
GFP-MAPAC  +  +  +  +  +  +  - 
GFP-NbPSP  +  +  +  +  -  - 
GFP-Nb  -  -  +  +  +  + 
GFP-PSP  +  +  +  +  +  +  +  + 
GFP-BD  ++++  ++++  - 
GFP-BDC  +  +  +  +  +  +  +  - 
GFP-PGGG  ±  -  +  +  + 
GFP-P~  -  -  +  +  +  + 
HA-BD  ++++  ++++  - 
HA-PSP  +  +  +  +  - 
HA-PGGG  +_  -  - 
HA-PGGGC  -  -  - 
Pluses  and minuses  are  arbitrary  designations  to  indicate  the  relative  activity  of the 
GFP chimeras.  See text for a  discussion of the differences  between  the GFP  and HA- 
tagged PSP construct. 
Figure  7.  Double-immunofluorescence staining  of BHK  cells 
transfected with  epitope tagged MAP 4 binding  domain.  Cells 
transiently transfected with HA-tagged basic domain were dou- 
ble-stained for tubulin  with a mAb to a-tubulin and the epitope 
tag with the 12CA5 mAb. Tubulin staining was visualized with a 
secondary antibody conjugated to Texas Red (A), and the MAP 
4 binding domain with a secondary antibody conjugated to fluo- 
rescein (B). The binding domain of MAP 4 is coincident with mi- 
crotubules. 
highly conserved among species, we examined the effect of 
its removal or addition on microtubule binding and orga- 
nization.  Surprisingly,  the  patterns  obtained  upon  trans- 
fection  of  GFP-MAPAC  (Fig.  9  A)  were  distinct  from 
those  obtained previously with full-length MAP 4  (com- 
pare to Fig. 3). Whereas the intact protein showed normal 
microtubule binding  and  organization at all levels of ex- 
pression, removal of the COOH-terminal region resulted 
in a moderate bundling phenotype. The frequency of mi- 
crotubule bundling was high, but the phenotype was not as 
severe or as extensive as that seen with the GFP-BD con- 
struct.  Polygonal arrays of noncentrosomal microtubules 
were occasionally seen,  and diffuse signal was never ob- 
served.  These  results  demonstrate  that  removal  of  the 
acidic COOH-terminal domain, comprising less than 6% 
of the  entire MAP 4 protein, still allows tight binding to 
microtubules, but modulates the activity of the MAP with 
respect to microtubule organization. 
An  effect of the  COOH-terminal  domain  on  MAP  4 
binding  is  confirmed  and  extended  in  experiments  that 
combine  this  region  with  portions  of the  basic  domain. 
Transfectants expressing the GFP-BDC construct showed 
microtubule rearrangements more similar to the BD phe- 
notype than  MAPAC  (Fig.  9  B),  although  bundles  were 
generally  smaller  and  thinner  and  rearrangements  were 
less  dramatic.  As  with  the  MAPAC  protein,  GFP-BDC 
showed no diffuse labeling, indicating that the microtubule 
affinity of the chimeras had not been significantly dimin- 
ished. However, the subtle differences in microtubule re- 
arrangements observed for GFP-BDC without any alter- 
ation in expression level again suggest a regulatory role for 
the  COOH-terminal domain. This notion  is further  sup- 
ported in transfections with the  GFP-PGGGC construct, 
shown in Fig. 9 C, where labeling was entirely diffuse, and 
the  rare  labeling  of  microtubules  seen  with  the  GFP- 
PGGG construct was never observed.  Collectively, com- 
parisons of microtubule rearrangements seen in chimeric 
proteins with  or without  the  acidic  COOH-terminal  do- 
main suggest that  this  domain modulates interactions  of 
the basic domain with microtubules, possibly as a result of 
its negative charge. 
The Projection Domain Shows No In Vivo Association 
with Microtubules, but Is Able to Regulate Interaction 
of the Basic Domain with Microtubules 
To identify the  role of the projection domain in MAP 4 
function and/or microtubule binding, we used the GFP-Nb 
construct encoding the entire acidic projection domain ex- 
tending from the amino terminus of MAP 4 to the border 
of the basic region. Cells transiently transfected with GFP- 
Nb displayed diffuse labeling, and showed no interaction 
with microtubules, regardless of expression level (Fig. 10 
A).  Unlike  the  nonlocalized  distribution  seen with  GFP 
alone,  however,  the  projection  domain  chimera  is  ex- 
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or GFP-PGGG constructs.  (A) Cell transfected with the GFP- 
PSP construct. The arrow in A points to a prominent microtubule 
bundle within the cell. (B) Cell transfected with the GFP-PGGG 
construct; note  the  diffuse  labeling.  Cells  shown  were  treated 
with sodium butyrate for 36 h. 
cluded from the nucleus, presumably because of its large 
size. The failure of GFP-Nb to associate with microtubules 
implies  that the projection domain does not form dimers 
with endogenous MAP 4. Whether other MAPs dimerize 
has been debated (see references 14 and 64). 
We next sought to determine the effect of the projection 
domain  on  interaction  of  the  PSP  region  with  micro- 
tubules.  Transfections  with  the  GFP-NbPSP  construct 
revealed that the chimeric protein associates with microtu- 
bules  in  a  manner  indistinguishable  from  that  of  full- 
length  MAP 4,  despite  missing  both  the  PGGG  repeats 
and COOH-terminal  domain (Fig.  10 B). This was a  sur- 
prising result,  as  a  chimera containing the projection  do- 
main  and  basic  binding  domain  (GFP-MAPAC)  showed 
distinct microtubule reorganization.  Interestingly, the dif- 
fuse labeling observed previously with  the  GFP-PSP chi- 
mera  was  absent  with  the  GFP-NbPSP construct.  These 
data  suggest that the projection  domain is capable of in- 
creasing  the  affinity of the  PSP region  for microtubules, 
but  without  causing  the  reorganization  of microtubules 
into bundles. 
Figure  9.  Live  BHK  cells  transiently  transfected  with  GFP- 
MAPAC,  GFP-BDC  or  GFP-PGGGC  constructs.  (A)  GFP- 
MAPAC;  (B)  GFP-BDC;  (C)  GFP-PGGGC.  The  arrow in  B 
indicates microtubules arranged in a polygonal lattice.  All cells 
shown were treated with sodium butyrate for 24 h. 
Treatment of Transfectants with Nocodazole 
Demonstrates Enhanced Stability of  Microtubule 
Bundles in the Presence of the GFP-BD and GFP-PSP 
We have observed distinct  microtubule  binding activities 
for the different MAP 4 constructs studied here, some of 
which were  characterized  by the  appearance  of microtu- 
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or GFP-NbPSP  vectors encoding  the acidic projection domain. 
(A) GFP-Nb;  (B) GFP-NbPSP.  Ceils were treated with sodium 
butyrate for 24 h. Note the absence of localization of fluorescence 
in A, and the strong localization to microtubules in B. 
bule bundles. A  plausible hypothesis is that the microtu- 
bule bundling seen with some of the constructs is a result 
of preferential stabilization  of microtubules. To test this 
idea, we asked if different classes of microtubules could be 
distinguished  by their sensitivity to microtubule depoly- 
merizing drugs. BHK cells stably expressing either GFP- 
MAP 4 or GFP-BD were incubated with 10 ixg/ml nocoda- 
zole for up to 60 min, and live cells were observed for the 
presence  of stable  microtubules.  Cells  expressing  GFP- 
MAP 4 or GFP-BD were observed every minute for sev- 
eral minutes  to follow the nocodazole-mediated depoly- 
merization of microtubules. As shown in comparing Fig. 
11, A and C, all the cellular microtubules in a cell express- 
ing  GFP-MAP  4  were  depolymerized within  5  min  of 
treatment. This is consistent with previously published re- 
sults indicating that MAP 4 does not have a stabilizing el- 
Figure 11.  Differential  resistance of microtubules to nocodazole 
in cells transfected  with MAP 4 or the basic domain. BHK cells 
transfected with either GFP-MAP 4 (A and C) or GFP-BD (B 
and D) were imaged before treatment (A and B) or after treat- 
ment with 10 ixg/ml  nocodazole for 5 min (C and D). Note the de- 
polymerization  of single microtubules in both C and D, but the 
persistence of the microtubule bundle in D. 
feet in cells treated with anti-mitotic agents  (3). In con- 
trast,  ceils  expressing  GFP-BD  displayed  two  readily 
distinguishable populations of microtubules. As shown in 
comparing Fig. 11, B with D, microtubules that were not 
bundled  depolymerized within  5  min,  whereas  those  in 
bundles persisted. The bundle shown was still present after 
30 min of observation, and bundles were observed in other 
cells after as long as 1-2 h of drug treatment. These data 
are consistent with experiments in which HA-tagged BD 
and microtubule patterns were compared by double im- 
munofluorescence; these  also showed that  only bundled 
microtubules persisted  after treatment with  nocodazole. 
Real-time  experiments  demonstrated  that  the  bundles 
produced by the GFP-PSP fusion protein were also stabi- 
lized  against  depolymerization (data  not  shown).  Thus, 
bundling caused by certain MAP 4 protein domains is cor- 
related with microtubule stabilization. 
Treatment of transfectants with taxol (10 lxM taxol for 
4--6 h) showed that the GFP chimeras generally followed 
the aberrant microtubule patterns generated by this drug 
(data  not  shown).  Interestingly,  GFP-PGGG  protein 
showed a higher degree of association with the taxol-stabi- 
lized microtubule bundles than in nontreated cells. These 
data suggest that the GFP-PGGG chimera is functional in 
microtubule binding, but has a lower affinity for dynamic 
microtubules. 
Discussion 
Results presented here demonstrate that GFP is an effec- 
tive reporter for subcellular structures like the cytoskel- 
eton, providing good temporal  and  spatial  resolution in 
living cells. We have used this reporter to show that GFP- 
MAP 4 mimics the behavior of both intact MAP 4 (3) and 
portions of MAP 4 tagged with an HA epitope, providing 
encouraging evidence that GFP, despite its 27-kD size, is a 
benign tag for studying the behavior of at least some pro- 
teins in vivo. The efficacy of GFP for such analyses is due 
partly to its relatively stable, high-intensity fluorescence 
that can be imaged in  living cells using standard  micro- 
scopic equipment. GFP phototoxicity and photobleaching 
are low, so cell physiology appears unimpaired during ob- 
servation. Moreover, the fluorescence of GFP, visualized 
with fluorescein filters, increases over the first 30 s of ex- 
amination, facilitating its use as a tag and suggesting the 
possibility of photoactivation experiments (e.g., reference 
52) for the study of binding kinetics. The ability to visual- 
ize  both  MAP  4  and  microtubules,  through  the  use  of 
rhodaminated tubulin injected into cells containing GFP- 
MAP 4 constructs, also opens the possibility of performing 
experiments in which the dynamics of these elements can 
be  analyzed simultaneously. This work  extends the pio- 
neering studies of GFP as a tag for protein behavior (19, 
61) and echoes newly reported work on ion channel chi- 
meras that shows the utility of GFP as an indicator of ex- 
pression levels (48). 
Our utilization of GFP for the dissection of MAP 4 do- 
main behavior has revealed that interaction of this protein 
with  microtubules  is  complex,  and  is  modulated  by se- 
quences  both  within  and  outside  the  basic  domain  re- 
quired  for  microtubule  binding  (see  Table  I).  Further, 
these studies have provided new evidence for the distinc- 
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tural  MAPs.  Full-length  GFP-MAP  4  chimeras,  either 
transiently or stably introduced into cells, localized to mi- 
crotubules and caused no microtubule reorganization in 
interphase or mitotic cells. In agreement with our previous 
findings (3), GFP-MAP 4 expression had no effect on the 
sensitivity of microtubules to depolymerizing drugs.  One 
function often attributed to the structural MAPs, including 
MAP 4 (8) is stabilization of microtubule arrays (3, 6, 32, 
37,  42,  45,  50,  62).  Our data indicate that  despite some 
overall structural similarities and strong sequence conser- 
vation of the PGGG repeats among MAP 2, tau and MAP 
4, MAP 4 in cycling cells is distinct from the neural MAPs 
in its effects on microtubule organization and dynamic in- 
stability. 
Our results show that the entire basic domain of MAP 4 
causes extensive rearrangement of microtubule arrays into 
bundles, stabilization of these bundles against depolymer- 
ization and, in rare instances, formation of polygonal lat- 
tices. The formation of bundles is similar to findings from 
the heterologous expression of analogous regions of MAP 
2 (39) and tau (6, 37), whereas the formation of the poly- 
gons is unique to MAP 4. Bundling in itself is a complex 
phenomenon (see reference 14) and there is some debate 
over whether the bundling observed with the neural MAPs 
may be a result of microtubule cross-bridging. Recent in 
vitro studies  (29)  indicate that tau-induced bundling oc- 
curs in the absence of cross-linking, implicating other fac- 
tors such as promotion of microtubule assembly and stabi- 
lization or neutralization of negative charge on the tubulin 
polymer.  Our  data  are  most  consistent with  a  bundling 
model based on increased stability and assembly of micro- 
tubules in the presence of GFP-BD and GFP-PSP. 
These in vivo studies showed that within the basic do- 
main, the PSP domain, unique to MAP 4, binds strongly to 
microtubules  and  induces  their  bundling,  whereas  the 
highly conserved PGGG repeat region has a low affinity 
for dynamic microtubules and is dispensable for normal 
microtubule  binding.  In  vitro experiments with  MAP  4 
have indicated that a region upstream from the PGGG re- 
peats has a  higher affinity for microtubules than the re- 
peats themselves, and can generate aberrant tubulin poly- 
mers  unless  linked  to  the  PGGG repeats  (1).  The  low 
affinity of either intact or individual PGGG repeats for 
microtubules  has  previously been  observed for tau  and 
MAP 2 both in vitro and in vivo (15, 24, 27, 29, 35). Our 
experiments indicate that the  binding of the  PGGG re- 
peats  is  enhanced  when  microtubules  are  stabilized  by 
taxol-treatment and  thus  that dynamic microtubules are 
poor substrates for its binding. In concert with the PSP do- 
main, however, a strong binding interaction occurs. These 
data are consistent with a current model for tau binding to 
microtubules in vitro that suggests that regions flanking 
the PGGG repeats act as "jaws" that aid in the placement 
and  binding  of the  repeats  (29).  Investigations  are  cur- 
rently  underway  to  determine  whether  the  conserved 
phosphorylation sites that lie within the PSP domain, and 
that include a cdc2 site, may modulate these binding inter- 
actions in vivo. 
Our analysis  of the  MAP 4  projection domain  (GFP- 
Nb) indicated that it does not itself associate with microtu- 
bules, but strongly modulates the activity of the binding 
domain. Although MAP 4 can dimerize in solution (11), 
the  diffuse cytoplasmic distribution  of this  domain sug- 
gests that this interaction does not occur in vivo. The ab- 
sence of binding is also consistent with in vitro studies in 
which a proteolytic fragment (1) or a bacterially expressed 
protein  (West  and  Olmsted,  unpublished  data)  corre- 
sponding to this acidic domain showed no affinity for mi- 
crotubules. The projection domain had an unexpected in- 
fluence, however, on the interaction of the PSP domain 
with microtubules. Cells transfected with GFP-NbPSP dis- 
played high-affinity microtubule binding identical to that 
seen with intact MAP 4, with no polymer rearrangements 
or diffuse labeling.  This contrasts with  the  PSP domain 
alone, which was capable of generating and binding to mi- 
crotubule  bundles  as  well  as  existing  in  a  nonlocalized 
state. Our results with this domain differ from those ob- 
tained with an analogous region of tau, which was unable 
to bind microtubules in vivo (44), and bound with only 
very low affinity (Kd of ~sl  mM)  in  vitro (29).  Collec- 
tively, these  data  indicate  that  the  nonconserved acidic 
regions  of different  structural  MAPs  account  for  their 
unique behaviors. 
One way in which the projection domain might exert its 
influence on the binding domain other than through direct 
interaction with the microtubule surface is via post-trans- 
lational modifications. Others have shown that phosphory- 
lation of MAP 2 decreases its affinity for microtubules (7) 
and that the protein structure of tau stiffens upon phos- 
phorylation, a process that could influence the affinity of 
the molecule for microtubules (4, 30, 47). The projection 
domain of MAP 4 has multiple (>50) potential sites for 
phosphorylation by cAMP-dependent kinase  and  casein 
kinase  II.  Although  it  has  been  shown  that  cell  cycle- 
dependent phosphorylation of MAP 4 occurs, presumably 
by cdc2 kinase (59, 60), whether these other sites are sig- 
nificant in the modulation of MAP 4 activity remains to be 
determined. 
While addition or removal of the large projection do- 
main might have been predicted to affect the behavior of 
MAP 4, it was surprising that the small acidic COOH-ter- 
minal  domain  had  a  pronounced  influence  on  MAP- 
microtubule interaction. This carboxy terminus is  highly 
conserved (90%) (63) in MAP 4 across species. A  similar 
region is found in MAP 2 and tau, and while conserved for 
any given structural MAP, collectively these domains do 
not strongly resemble one another. In vivo and in vitro 
analyses with tau have shown that the carboxy terminus 
enhances both association of the binding domain with mi- 
crotubules and bundling (6, 37). Our results with MAP 4 
constructs are in direct contrast to those seen with tau. In 
cases where the carboxy terminus was included within a 
construct (e.g., GFP-BDC or GFP-PGGGC), there was a 
general decrease in either microtubule reorganization or 
microtubule binding, respectively, with no corresponding 
increase in the amount of nonlocalized signal. Conversely, 
deletion of the carboxy terminus from full-length MAP 4 
(less than 6% of the protein) resulted in mild reorganiza- 
tion of microtubules and variable amounts of microtubule 
bundling. These results all suggest that the acidic COOH 
terminus plays a significant role in the interaction of the 
binding domain with microtubules, but whether this is due 
to charge or steric interactions is not yet resolved. 
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structs of MAP 4 (summarized in Table I) lead to a model 
for  the  association  of  this  protein  with  microtubules  in 
vivo. The entire basic region of MAP 4 is directly involved 
in microtubule binding, with the nonconserved PSP flank- 
ing sequence  serving as the primary association domain. 
This domain alone is able to bind to microtubules and sta- 
bilize them against depolymerization with nocodazole, al- 
though with lower activity than the intact binding domain. 
In the presence of the projection domain, the PSP region is 
able to perform as a  functional microtubule binding  do- 
main with characteristics  indistinguishable  from the  full- 
length protein in the assays used here.  We  propose that 
the PSP domain directs MAP 4 to the surface of microtu- 
bules, and that the PGGG repeats may then enhance bind- 
ing, but are themselves unable to bind efficiently in vivo. 
This  implies  that  the  PGGG  repeats  serve  some  other 
function  associated  with  microtubule  assembly,  such  as 
stabilization of assembled tubulin dimers. Once bound to 
the microtubule surface, the basic domain can alter exist- 
ing arrays of microtubules in a dominant negative fashion 
if not properly regulated. Addition of either acidic domain 
of MAP 4 (the projection domain or the COOH terminus) 
to the  basic region modifies this interaction.  Studies  are 
currently in progress to determine how some of the tissue- 
specific  splicing  variants  and  posttranslational  modifi- 
cations that occur in various regions of MAP 4  may con- 
tribute to the overall regulation of the molecule. With the 
development  of  GFP-MAP  4  chimeras  and  stable  cell 
lines,  and with the ability to visualize MAP  on rhodami- 
nated microtubules, it will also now be possible to test di- 
rectly how these modifications influence the dynamics of 
both MAPs and microtubules in vivo. 
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